Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | DGKA | P23743 | 2/20 | 0.62 |
| ▸ | PRKCA | P17252 | 3/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.60 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.59 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.59 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.59 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2115586 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| Propylene Glycol Monostearate SCHEMBL4429462 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL141668 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL1730481 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL29649070 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL180498 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL629794 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL26974 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| Propylene Glycol Monostearate SCHEMBL35521 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL1173237 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2587 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137627-A1 | ENCAPSULATION OF POORLY WATER SOLUBLE COMPOUNDS USING OSA-MODIFIED NON-STARCH POLYSACCHARIDES | KANSAS STATE UNIV RESEARCH FOUNDATION (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026104851-A1 | PHARMACEUTICAL COMPOSITIONS | Apollo AP10 Limited (GB) | 2026-05-21 | — | — | WO | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| US-12605318-B2 | Synergistic preservative/personal care composition containing an alkylene glycol ester | ARCH UK BIOCIDES LTD (GB) | 2026-04-21 | — | — | US | claimed |
| EP-4554551-B1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2026-03-11 | — | — | EP | claimed |
| EP-4701417-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING A CATIONIC ANTIMICROBIAL AND AN ACIDIC GLYCOLIPID | LANXESS Corporation (US) | 2026-03-04 | — | — | EP | claimed |
| EP-4687850-A1 | ORAL DRUG DOSAGE FORMS FOR COLON DELIVERY AND METHODS OF USE AND MAKING THEREOF | Triastek, Inc. (CN) | 2026-02-11 | — | — | EP | claimed |
| US-20260027123-A1 | Compositions for Modulating Lipoxygenase and Methods of Using Same | UNIV CALIFORNIA (US) | 2026-01-29 | — | — | US | claimed |
| US-20260021051-A1 | PHARMACEUTICAL FORMULATIONS | VIVUS LLC (US) | 2026-01-22 | — | — | US | claimed |
| EP-3934753-B1 | MICROBIAL REMOVAL | CAPRETTO EHF (IS) | 2025-11-05 | — | — | EP | claimed |
| CN-1211085-C | Compositions having improved stability | PROCTER & GAMBLE (US) | 2005-07-20 | — | — | CN | claimed |
| EP-1250331-B1 | FORMULATION FOR PROTECTION AGAINST OXIDATIVE STRESS CONTAINING BENZOFURANONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2004-11-03 | — | — | EP | claimed |
| EP-1178850-B1 | ANTIMICROBIAL ARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2003-10-29 | — | — | EP | claimed |
| US-20020165286-A1 | Dermal anti-inflammatory composition | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 2002-11-07 | — | — | US | claimed |
| WO-2002045752-A2 | DERMAL ANTI-INFLAMMATORY COMPOSITION | LEO PHARMA A/S (DK) | 2002-06-13 | — | — | WO | claimed |
| US-5744137-A | WATER IN OIL EMULSION VACCINE HAVING ANTIGEN DIRECTLY EMULSIFIED INTO OIL PHASE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AGRICULTURE (US) | 1998-04-28 | — | — | US | claimed |
| WO-1996024374-A1 | OIL EMULSION VACCINES PREPARED WITH ANIMAL, VEGETABLE, AND SYNTHETIC OILS USING A MIXTURE OF NONIONIC SURFACTANTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF AGRICULTURE (US) | 1996-08-15 | — | — | WO | claimed |
| EP-0461630-B1 | Production process of microspheres | EISAI CO LTD (JP) | 1995-09-13 | — | — | EP | claimed |
| EP-0653617-A2 | Fat-soluble substituting agent for substituting dehydrating agent for producing tissue preparation | Shino, Junko (JP) | 1995-05-17 | — | — | EP | claimed |
| US-4205086-A | FATTY ACIDS OR ESTERS | Stokeley-Van Camp, Inc. (US) | 1980-05-27 | — | — | US | claimed |